Rheumatology

EULAR 2024

Letter from the Editor

Editor

Prof. Dennis McGonagle, University of Leeds, UK

Conference

EULAR 2023

29 July 2024 14:40

Nipocalimab meets primary endpoint in Sjögren’s syndrome

Presented By

Prof. Jacques-Eric Gottenberg, Strasbourg University Hospital, France

Trial

Phase 2, DAHLIAS

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:38

Advanced therapies show promising results in PsA real-world study

Presented By

Prof. Dennis McGonagle, University of Leeds, UK

Trial

PRO-SPIRIT

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:38

Dual IL-17A/F blocker significantly reduces spinal radiographic progression in radiographic axSpA

Presented By

Prof. Xenofon Baraliakos, Ruhr-University Bochum, Germany

Trial

Phase 3, BE MOBILE 2

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:38

Small protein targeting IL-17A effective in PsA management

Presented By

Prof. Philip Mease, University of Washington; Swedish Medical Center, WA, USA

Trial

Phase 2

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:37

New JAK1 inhibitor outperforms placebo in active RA

Presented By

Dr Jinjing Liu, Peking Union Medical College Hospital, China

Trial

Phase 3

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:37

Macrophage profiling in synovial tissue predicts treatment response in RA

Presented By

Dr Simone Perniola, Policlinico Universitario A. Gemelli IRCS, Italy

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:36

Innovative app boosts mental health in patients with RA

Presented By

Prof. Frank Behrens, Goethe-University & Fraunhofer ITMP, Germany

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:35

Daratumumab shows promise in systemic lupus erythematosus

Presented By

Dr Tobias Alexander, Charité-University Medicine Berlin, Germany

Trial

Phase 2

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:35

Severe lung involvement in SSc linked to anti-Ro/SSA antibodies

Presented By

Dr Blaž Burja, University Hospital Zurich, Switzerland

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:35

Early treatment with ambrisentan might prevent PAH development in patients with SSc

Presented By

Dr Panagiota Xanthouli, Heidelberg University Hospital, Germany

Trial

Phase 2, EDITA

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:34

More patients hit their uric acid target with febuxostat and ruzinurad combination

Presented By

Dr Huihua Ding, Shanghai Jiao Tong University, China

Trial

Phase 2

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:34

Tophaceous gout at higher mortality risk than non-tophaceous gout

Presented By

Dr Gregory Challener, Massachusetts General Hospital, MA, USA

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:33

Is JAK inhibition the right choice for patients with relapsing giant cell arteritis?

Presented By

Dr Fernando López Gutiérrez, University Hospital Ramón y Cajal, Spain

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:33

Giant cell arteritis: Upadacitinib may be an upcoming treatment option

Presented By

Prof. Daniel Blockmans, University Hospitals Leuven, Belgium

Trial

Phase 3, SELECT-GCA

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:33

AxSpA: Higher comorbidity burden worsens radiographic progression

Presented By

Dr Sizheng Steven Zhao, University of Manchester, UK

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:32

Hope for a durable effective injection therapy in knee osteoarthritis

Presented By

Prof. Philip Conaghan, University of Leeds, UK

Trial

Phase 2, SPRINGBOARD

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:31

Dermatomyositis: Triple therapy with tacrolimus beats cyclosporin regimen

Presented By

Prof. Yasuhiro Katsumata, Tokyo Women’s Medical University, Japan

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:31

Less fracture risk with denosumab than bisphosphonates in pre-treated osteoporosis

Presented By

Prof. Jeffrey Curtis, University of Alabama at Birmingham, AL, USA

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:29

Low IL-18: a hidden culprit of long COVID in patients with autoimmune disease

Presented By

Dr Jeffrey Sparks, Brigham and Women's Hospital, MA, USA

Trial

RheumCARD

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:29

Stopping DMARDs? These key factors predict RA flares

Presented By

Dr Fiona Rayner, Newcastle University, UK

Trial

BIO-FLARE

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:27

ACR 2023

EULAR 2023

Letter from the Editor

Editor

Prof. Dennis McGonagle, University of Leeds, UK

Conference

EULAR 2023

31 July 2023 07:21

In vitro and in vivo studies confirm the role of regulatory volume decrease

Presented By

Dr Twinu Wilson Chirayath, Paris Cité University, France

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:54

Therapy with biological DMARDs shows no correlation with fracture risk in RA

Presented By

Ms Ingebjorg Tronstad, Norwegian University of Science and Technology, Norway

Trial

HUNT

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:50

Bimekizumab: high rates of sustained response in PsA

Trial

Phase 3, BE OPTIMAL

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:46

Drugs for osteoporosis: time to reach fracture risk reduction varies

Presented By

Dr Giovanni Adami, University of Verona, Italy

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:41

Romosozumab: the new option for glucocorticoid-induced osteoporosis with high fracture risk?

Presented By

Dr Chi Chiu Mok, Tuen Muk Hospital, China

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:38

Targeted DMARDs advantageous in SSc patients with pre-capillary pulmonary hypertension

Presented By

Dr Cosimo Bruni, University Hospital Zurich, Switzerland

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:33

Lorecivivint shows long-term benefits for severe knee OA

Presented By

Prof. Timothy McAlindon, Tufts University School of Medicine, MA, USA

Trial

Phase 3, STRIDES-X-ray

Conference

EULAR 2023

31 July 2023 06:29

Methotrexate lowers pain in inflammatory hand OA

Presented By

Prof. Flavia Cicuttini, Monash University, Australia

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:25

AxSpA: Adalimumab biosimilar equally effective as IL-17 inhibitor in hindering radiographic progression

Presented By

Prof. Xenofon Baraliakos, Rheumazentrum Ruhrgebiet, Germany

Trial

Phase 3, SURPASS

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:22

Vascular inflammation may be characteristic of PsA

Presented By

Dr Nienke Kleinrensink, UMC Utrecht, the Netherlands

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:18

Obesity in PsA is increasingly affecting male patients

Presented By

Dr Marlene Stirnimann-Agustoni, University Hospital of Zürich, Switzerland

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:13

PsA patients: highest risk of developing NAFLD

Presented By

Mr Anthony Harrison, Leeds Teaching Hospitals NHS Trust, UK

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:09

Poly-refractory RA: not common, but still present

Presented By

Dr Paula David, University of Leeds, UK

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:04

COBRA-Slim bio-induction: no benefit compared with the standard regimen

Trial

CareRA2020

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 05:59

AI almost as successful as experts in predicting early RA

Presented By

Dr Yanli Li, Leiden University Center, the Netherlands

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 05:54

Worse self-management in patients with inflammatory arthritis in the presence of comorbid anxiety or depression

Presented By

Ms Sofie Bech Vestergaard, Aarhus University Hospital, Denmark

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 05:51

Disease activity-guided dose reduction may be a long-term option for stable RA

Presented By

Dr Noortje van Herwaarden, Sint Maartenskliniek, the Netherlands

Trial

DRESS

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 05:40

Cardiovascular safety of JAK inhibitors: reassuring results from a real-world study

Presented By

Mr Romain Aymon, Geneva University Hospital, Switzerland

Trial

ORAL Surveillance

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 00:00

Selective JAK1/TYK 2 inhibitor effective in patients with difficult-to-treat RA

Presented By

Prof. Xiaofeng Zeng, Peking Union Medical College Hospital, China

Conference

EULAR 2023

Type

Peer-reviewed article

30 July 2023 23:53

Novel 2-drug combo improves treatment possibilities for patients with refractory gout

Presented By

Prof. Herbert SB Baraf, Center for Rheumatology and Bone Research, IL, USA

Trial

Phase 3, DISSOLVE I, II

Conference

EULAR 2023

Type

Peer-reviewed article

30 July 2023 23:34

Dazodalibep improves dryness, fatigue, and pain in patients with Sjögren’s syndrome with a high symptom burden

Presented By

Dr Chiara Baldini, University of Pisa, Italy

Trial

ALISS

Conference

EULAR 2023

Type

Peer-reviewed article

30 July 2023 23:25

COVID-19: Young adults with auto-immune diseases have different risks than their healthy counterparts

Presented By

Dr Alessia Alunno, University of L’Aquila, Italy

Conference

EULAR 2023

Type

Peer-reviewed article

30 July 2023 23:20

EULAR 2023 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

EULAR 2023

18 June 2023 22:24

ACR 2022

EULAR 2022

Letter from the Editor

Editor

Prof. Dennis McGonagle, University of Leeds, United Kingdom

Conference

EULAR 2022

22 July 2022 11:36

Alarmingly low activity in patients with non-inflammatory and inflammatory rheumatic disease

Presented By

Prof. Luca Quartuccio, University of Udine, Italy

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 19:31

High prevalence of fibromyalgia in patients with inflammatory bowel disease

Presented By

Dr Laura Guida , Luigi Sacco University Hospital, Italy

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 19:27

Inhibition of Bruton’s tyrosine kinase: a new way of approaching SLE?

Presented By

Prof. Zangou Li , Peking University People’s Hospital, China

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 19:21

Pregnancies in SLE: many complications for mothers and their unborn children

Presented By

Prof. Bella Mehta , Weill Cornell Medical College, NY, USA

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 19:16

Lupus nephritis: Efficient treatment may reduce the risk of kidney disease advancement

Presented By

Prof. Konstantinos Tselios , McMaster University, Canada

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 18:10

Antifibrotic therapy with nintedanib is beneficial for patients with negative prognostic factors

Presented By

Prof. Christopher Denton , University College London, United Kingdom

Trial

Phase 3, SENSCIS

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 18:07

New treatments in osteoarthritis

Presented By

Prof. Tonia Vincent , University of Oxford, United Kingdom

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 18:01

OA associated with alcohol and drug abuse

Presented By

Dr Anne Kamps, Erasmus University Medical Center, the Netherlands

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 17:55

Body mass index increase associated with structural changes in knee OA

Presented By

Dr Zubeyir Salis, University of New South Wales, Australia

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 17:52

How to treat enthesitis in 2022

Presented By

Prof. Dennis McGonagle, University of Leeds, United Kingdom

Trial

Phase 3, SEAM-PsA, EXCEED, SPIRIT-H2H

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 17:42

Baseline cardiovascular risk linked to higher rates of MACE in PsA and PsO patients receiving tofacitinib

Presented By

Prof. Lars Erik Kristensen , Copenhagen University Hospital, Denmark

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 17:30

Treat-to-target dose reduction effective in spondyloarthritis

Presented By

Dr Celia Michielsens , Sint Maartenskliniek, the Netherlands

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 17:21

A novel oral treatment possibility for non-radiographic axSpA on the horizon

Presented By

Prof. Filip van den Bosch , Ghent University, Belgium

Trial

Phase 3, SELECT-AXIS 2

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 17:17

Many RA and PsA patients have problems with their sex life

Presented By

Dr Carlos Valera-Ribera , Doctor Peset University Hospital, Spain

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 17:12

Comorbid depression comes with a profoundly higher mortality risk in RA

Presented By

Dr Jens Kristian Pedersen, Odense University Hospital, Denmark

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 15:10

Preventive treatment with methotrexate benefits pre-RA patients with arthralgia

Presented By

Dr Doortje Krijbolder, Leiden University Medical Center, the Netherlands

Trial

TREAT EARLIER

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 15:07

Risk factors for dementia in RA patients discovered

Presented By

Prof. Elena Myasoedova , Mayo Clinic, MN, USA

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 15:02

VTE in global registry data more common in JAK inhibitor-treated RA patients

Presented By

Prof. Adeline Ruyssen-Witrand, Toulouse University Hospital, France

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 14:52

TYK2 inhibition: the future of treating lupus erythematosus?

Presented By

Prof. Eric Morand , Monash University, Australia

Trial

Phase 2, PAISLEY

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 14:45

Psoriatic arthritis: significant improvement with bimekizumab

Presented By

Prof. Iain McInnes , Glasgow University, United Kingdom

Trial

Phase 3, BE OPTIMAL

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 14:36

Baricitinib could open the door to oral treatment for juvenile idiopathic arthritis

Presented By

Prof. Athimalaipet Ramanan , Bristol Medical School, United Kingdom

Trial

Phase 3, JUVE-BASIS

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 14:22

Sarilumab for polymyalgia rheumatica led to sustained remission and fewer flares

Presented By

Prof. Bhaskar Dasgupta , Anglia Ruskin University, United Kingdom

Trial

Phase 3, SAPHYR

Conference

EULAR 2022

21 July 2022 14:05

EULAR 2022 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

EULAR 2022

22 June 2022 23:51

Downloadable 1-Page Selected Trial PowerPoint Slides

Conference

EULAR 2022

4 June 2022 14:30

ACR 2021

Letter from the Editor

Editor

Prof. Dennis McGonagle, University of Leeds, United Kingdom

Conference

EULAR 2021

14 January 2022 11:14

Vaccine booster improves immune response in patients treated with rituximab

Presented By

Prof. Michael Bonelli, Medical University of Vienna, Austria

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 11:07

IL-17 inhibition showing efficacy in GCA in phase 2 trials

Presented By

Prof. Jens Thiel, Medical University Graz, Austria

Trial

Phase 2, TitAIN

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 11:05

Cycling JAK inhibitors shows similar effectiveness to switching to a bDMARD in difficult-to-treat RA

Presented By

Dr Manuel Pombo-Suarez, Hospital Clinico Universitario de Santiago De Compostela, Spain

Trial

JAK-pot

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 11:03

Pre-existing heart failure affects safety of hydroxychloroquine in RA patients

Presented By

Dr Elvira D’Andrea, Brigham and Women’s Hospital, MA, USA

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 11:01

Patients with RA-associated interstitial lung disease benefit from antifibrotic agent

Presented By

Prof. Joshua J. Solomon, National Jewish Health, CO, USA

Trial

Phase 2, TRAIL1

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:59

Ultra-low dosing of rituximab in RA is a viable treatment option

Presented By

Mr Nathan den Broeder, Sint Maartenskliniek, the Netherlands

Trial

REDO

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:58

Kidney disease and hydroxychloroquine dose are risk factors for developing retinopathy

Presented By

Dr April Jorge, Massachusetts General Hospital, MA, USA

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:55

More pros than cons for the use of statins in RA

Presented By

Dr Gulsen Ozen, University of Nebraska Medical Center, NE, USA

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:54

Selective IL-23 inhibition: a new option in active PsA

Presented By

Prof. Andrew Östör, Monash University, Australia

Trial

Phase 3, KEEPsAKE 1, KEEPsAKE 2

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:52

Ustekinumab: highly efficacious in PSA independent of methotrexate

Presented By

Dr Michaela Köhm, Goethe-University Frankfurt, Germany

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:48

Vaccinated rheumatic patients carry increased risk for COVID-19 breakthrough infections

Presented By

Prof. Jasvinder Singh, University of Alabama at Birmingham, AL, USA

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:47

B-cell depleting medication increases COVID-19 breakthrough infection outcome risk

Presented By

Prof. Jean Liew, Boston University, MA, USA

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:45

COVID-19 mRNA vaccine safe and tolerable in adults with autoimmune disease

Presented By

Dr Inés Colmegna, McGill University Health Centre, Canada

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:06

Iberdomide: an upcoming new treatment possibility in lupus erythematosus

Presented By

Prof. Joan Merrill, Oklahoma Medical Research Foundation, OK, USA

Trial

Phase 2

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:04

Sequential rituximab after belimumab does not improve disease control in SLE

Presented By

Prof. Cynthia Aranow, Feinstein Institutes for Medical Research, NY, USA

Trial

Phase 3, BLISS-BELIEVE

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:02

Lupus patients less protected by COVID-19 vaccine

Presented By

Dr Peter Izmirly, New York University Grossman School of Medicine, NY, USA

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:00

Promising results in uric acid-lowering in gout patients with a new xanthine oxidase inhibitor

Presented By

Prof. Robert Terkeltaub, University of California San Diego, CA, USA

Trial

Phase 2

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 09:58

Laboratory and clinical signs 24h after hospitalisation predict MIS-C in children

Presented By

Dr Matthew Clark, Vanderbilt University Medical Center, TN, USA

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 09:55

ACR 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ACR 2021

22 November 2021 16:18

EULAR 2021

JAK inhibitors and bDMARDs not associated with increased risk of serious infections in RA

Presented By

Dr Anja Strangfeld, German Rheumatism Research Centre Berlin, Germany

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 23:53

Rituximab or JAK inhibitors increase the risk of severe COVID-19

Presented By

Dr Jeffrey Sparks, Brigham and Women’s Hospital, MA, USA

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 23:36

Efficacy and safety of secukinumab in juvenile idiopathic arthritis

Presented By

Dr Nicola Ruperto, IRCCS Istituto G. Gaslini, Italy

Trial

Phase 3, JUNIPERA

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 23:33

Intensified treatment regimen of anifrolumab for lupus nephritis is promising

Presented By

Prof. David Jayne, University of Cambridge, UK

Trial

Phase 2, TULIP-LN

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 23:29

Gene-diet and gene-weight interactions associated with the risk of gout

Presented By

Dr Chio Yokose, Massachusetts General Hospital, USA

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 23:26

SELECT-AXIS: 64-week results of upadacitinib in active ankylosing spondylitis

Presented By

Dr Atul Deodhar, Oregon Health & Science University, OR, USA

Trial

SELECT-AXIS 1

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 23:25

Air pollution predicts decreased response to biological treatment in rheumatic diseases

Presented By

Dr Giovanni Adami, University of Verona, Italy

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 23:22

PET/CT is a reliable measure of disease activity in LVV, but does not predict future relapses

Presented By

Dr Elena Galli , University of Modena and Reggio Emilia, Italy

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 23:14

Remote management of RA is a feasible alternative for outpatient follow-up

Presented By

Dr Mwidimi Ndosi, University of the West of England, UK

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 22:57

Updates on COVID-19 vaccines in patients with rheumatic disease

Presented By

Dr Victoria Furer, Tel Aviv Sourasky Medical Center, Israel

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 22:44

Passive smoking associated with an increased risk of RA

Presented By

Dr Yann Nguyen, Université Paris-Saclay, France

Trial

Cohort study, E3N-EPIC

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 22:24

Ultrasound is useful for disease monitoring in giant cell arteritis

Presented By

Dr Cristina Ponte, Hospital de Santa Maria Lisbon, Portugal

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 22:19

Guselkumab efficacious in PsA patients with inadequate response to TNF inhibition

Presented By

Dr Laura Coates , University of Oxford, UK

Trial

Phase 3, COSMOS

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 22:06

Immunomodulatory therapies for severe COVID-19: literature update

Presented By

Dr Alessia Alunno, University of Perugia, Italy

Trial

RECOVERY, REMAP-CAP

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 21:50

Faecal microbiota transplantation not effective in active peripheral PsA

Presented By

Dr Maja Skov Kragsnaes , University of Southern Denmark, Denmark

Trial

FLORA

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 21:08

TOVERA: Ultrasound is a promising biomarker of early treatment response

Presented By

Dr Maria Stoenoiu, Cliniques Universitaires Saint-Luc, Belgium

Trial

Phase 3, TOVERA

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 21:00

Risankizumab meets primary and ranked secondary endpoints in PsA

Presented By

Prof. Andrew Östör, Monash University, Australia

Trial

Phase 3, KEEPsAKE 2

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 20:10

The risks of polypharmacy in RA

Presented By

Dr Soraya Benamar, University Hospital of Montpellier, France

Trial

Cohort study, ESPOIR

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 20:02

ABBV-3373: A potential new therapeutic agent for RA

Presented By

Dr Frank Buttgereit, Charité University Medicine, Germany

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 19:05

Emerging therapies and future treatment directions in osteoarthritis

Presented By

Prof. Xavier Chevalier, University Paris-Est Créteil, France

Trial

FORWARD, CANTOS

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 18:35

Systemic lupus erythematosus: increased risk of severe infection

Presented By

Mr Kai Zhao, Simon Fraser University, Canada

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 18:31

Prognostic factors for minimal disease activity in early psoriatic arthritis revealed

Presented By

Prof. Tatiana Korotaeva, Nasonova Research Institute of Rheumatology, Russia

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 18:13

Letter from the Editor

Editor

Prof. Dennis McGonagle, University of Leeds, United Kingdom

Conference

EULAR 2021

2 August 2021 12:40

JAK inhibitors and bDMARDs show comparable effectiveness

Presented By

Mr Andrei Barbulescu, Karolinska Institutet, Sweden

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 10:23

EULAR 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

EULAR 2021

24 June 2021 15:06

Updates on COVID-19 vaccines in patients with rheumatic disease

Presented By

Dr Victoria Furer, Dr Pedro Machado

Conference

EULAR 2021

8 June 2021 09:53

Gene-diet interaction associated with the risk of gout

Presented By

Dr Chio Yokose, Massachusetts General Hospital, USA

Conference

EULAR 2021

8 June 2021 09:53

Systemic lupus erythematosus: increased risk of severe infection

Presented By

Mr Kai Zhao, Simon Fraser University, Canada

Conference

EULAR 2021

8 June 2021 09:52

The risks of polypharmacy in rheumatoid arthritis

Presented By

Dr Soraya Benamar, University Hospital of Montpellier, France

Trial

Cohort study, ESPOIR

Conference

EULAR 2021

8 June 2021 09:41

PET/CT is a reliable outcome measure of disease activity in large-vessel vasculitis

7 June 2021 10:15

Mavrilimumab outperforms placebo in severe COVID-19

Presented By

Dr Lara Pupim, Kiniksa Pharmaceutical Corp., USA

Conference

EULAR 2021

7 June 2021 10:15

Efficacy and safety of secukinumab in juvenile idiopathic arthritis

7 June 2021 10:14

Air pollution predicts decreased response to biological treatment in rheumatic diseases

Presented By

Dr Giovanni Adami, University of Verona, Italy

Conference

EULAR 2021

3 June 2021 10:39

No effect of faecal microbiota transplantation in active peripheral psoriatic arthritis

Presented By

Dr Maja Skov Kragsnaes, University of Southern Denmark, Denmark

Trial

FLORA

Conference

EULAR 2021

3 June 2021 10:13

Passive smoking associated with an increased risk of rheumatoid arthritis

Presented By

Dr Yann Nguyen, Université Paris-Saclay, France

Trial

Cohort study, E3N-EPIC

Conference

EULAR 2021

3 June 2021 10:00

Prognostic factors for minimal disease activity in early psoriatic arthritis revealed

Presented By

Prof. Tatiana Korotaeva, Nasonova Research Institute of Rheumatology, Russian Federation

Conference

EULAR 2021

3 June 2021 09:37

Ultrasound: promising biomarker for treatment response in very early RA

Presented By

Dr Maria Stoenoiu, Cliniques Universitaires Saint-Luc, Belgium

Trial

Phase 3, TOVERA

Conference

EULAR 2021

3 June 2021 09:23

WPPAC 2021

Unresolved needs for patients with PsA despite growing therapeutic options

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 13:46

PsoBarrier EU: Large survey evaluating quality of care in Europe

Presented By

Dr Anna Langenbruch, Universitätsklinikum Hamburg-Eppendorf, Germany

Trial

PsoBarrier EU

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 13:43

Bridging the gap between patients and access to psoriasis specialists

Presented By

Dr Silvia Fernandez Barrio, AEPSO, Argentina

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 13:42

Psoriasis and PsA in transgender adults on hormone therapy

Presented By

Ms Julia Gao, Fenway Health, MA, USA

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 13:41

Psoriasis: New disease severity classification

Presented By

Prof. Lone Skov, University of Copenhagen, Denmark

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 13:39

Active PsA: Biomarkers distinguish radiographic progressors from non-progressors

Trial

Phase 3, SPIRIT-P1

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 13:37

Immune checkpoint inhibitors in patients with pre-existing psoriasis

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 13:35

Axial involvement is critical in psoriatic arthritis

Presented By

Dr Elena Gubar, Nasonova Research Institute of Rheumatology, Russia

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 13:34

Psoriasis registries yield important data about COVID-19

Presented By

Dr Satveer Mahil, St John’s Institute of Dermatology, UK

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 12:35

COVID-19 affects patients and care

Presented By

Prof. Peter van de Kerkhof, Radboudumc, the Netherlands

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 12:33

Vaccination feasible in people with psoriatic disease

Presented By

Prof. Ulrich Mrowietz, University Medical Centre Schleswig-Holstein, Germany

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 12:30

Low COVID-19 risk for patients with psoriasis on biologic treatment

Presented By

Dr Jorge Georgakopoulos, University of Toronto, Canada

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 12:28

Psoriasis: Disrupted gut-skin axis

Presented By

Dr Mariusz Sikora, Medical University of Warsaw, Poland

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 12:22

Psoriasis associated with increased duodenum inflammation

Presented By

Prof. Maria Lampinen, Uppsala University, Sweden

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 12:20

Whole-exome sequencing to study the underlying pathogenesis of psoriasis

Presented By

Mr Sigurgeir Olafsson, University of Cambridge, UK

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 12:19

Pan-European guidelines for the treatment of psoriasis and comorbid conditions

Presented By

Prof. Alexander Nast, Charité Universitätsmedizin Berlin, Germany

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 12:09

Psoriatic arthritis: Guidelines and best practice

Trial

Phase 3, BE ACTIVE, PATERA

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 11:19

Patients with PsA have a higher cardiovascular risk

Presented By

Dr Natalia Guajardo-Jauregui, Autonomous University of Nuevo León, Mexico

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 11:16

Potential role of inflammation in cardiovascular comorbidity

Presented By

Dr Alexander Egeberg, Herlev and Gentofte Hospital, Denmark

Trial

Phase 3, CANTOS, CIRT

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 11:13

Psoriasis: New treatments and current pipeline

Presented By

Prof. Kristian Reich, Dermatologikum Hamburg, Germany

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 11:08

Rapid pustule and skin clearance with IL-36 receptor inhibitor spesolimab

Presented By

Prof. Hervé Bachelez, Hôpital Saint-Louis, France

Trial

Phase 2, Effisayil 1

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 11:04

Selective TYK2 inhibitor effective in moderate-to-severe plaque psoriasis

Trial

Phase 3, POETYK PSO-1, POETYK PSO-2

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 10:59

Letter from the Editor

Editor

Prof. Peter C.M. van de Kerkhof, Radboud University Medical Center, the Netherlands

Conference

WPPAC 2021

16 September 2021 14:03

IFPA WPPAC 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

WPPAC 2021

20 July 2021 16:16

ACR 2020

Letter from the Editor

Editor

Prof. Dennis McGonagle, University of Leeds, UK

Conference

ACR 2020

18 January 2021 11:38

Gout treatment with febuxostat: no higher cardiovascular mortality

Presented By

Prof. Thomas MacDonald, University of Dundee, UK

Trial

CARES, FAST

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 11:03

New agent with great potential for the treatment of giant cell arteritis in the pipeline

Presented By

Dr Maria Cinta Cid, Hospital Clínic of Barcelona, Spain

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 11:02

Autotaxin inhibitor successful in the first trial in diffuse cutaneous systemic sclerosis

Presented By

Prof. Dinesh Khanna, University of Michigan Scleroderma Program, USA

Trial

Phase 2, NOVESA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 11:02

JAK inhibition as a treatment option for ankylosing spondylitis

Presented By

Prof. Atul Deodhar, Oregon Health & Science University, USA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 11:02

Persuasive long-term results for JAK inhibition in rheumatoid arthritis

Presented By

Prof. Josef Smolen, Medical University of Vienna, Austria

Trial

Phase 3, SELECT-MONOTHERAPY

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 11:00

Rheumatoid arthritis: new EULAR treatment guidelines

Presented By

Prof. Daniel Aletaha, Medical University Vienna, Austria

Trial

IDEA, NORD-STAR

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 11:00

Rheumatoid arthritis and interstitial lung disease: a deadly combination

Presented By

Prof. Joan Bathon, Columbia University, USA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:59

COVID-19 in patients with rheumatic disease: most report mild disease

Presented By

Dr Akhil Sood, University of Texas Medical Branch, USA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:57

Poor disease control: a risk factor for severe COVID-19

Presented By

Prof. Rebecca Grainger, University of Otago, New Zealand

Trial

COVID-19 Global Rheumatology Alliance Registry

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:57

No heightened outcome risk for rheumatic patients with COVID-19

Presented By

Dr Naomi Serling-Boyd, Massachusetts General Hospital, USA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:56

Lupus nephritis biomarkers: moving toward an omic-driven approach

Presented By

Prof. Chaim Putterman, Albert Einstein College of Medicine, USA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:54

Lupus nephritis: new therapies on the horizon in 2020

Presented By

Prof. Joan T. Merrill, Oklahoma Medical Research Foundation, USA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:54

Signs of benefit for T2T in axial spondyloarthritis

Trial

Cohort study, TICOSPA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:53

Artificial intelligence can help in the diagnosis of axSPA

Presented By

Prof. Denis Poddubnyy, Charité Universitätsmedizin Berlin, Germany

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:53

Resolution of dactylitis or enthesitis is associated with improvements in joint and skin symptoms

Presented By

Prof. Dennis McGonagle, University of Leeds, UK

Trial

Phase 3, DISCOVER-1 & -2

Conference

ACR 2020

18 January 2021 10:51

Promising novel treatment option for psoriatic arthritis

Presented By

Prof. Philip J. Mease, University of Washington, USA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:51

How to choose imaging modalities in large vessel vasculitis

Presented By

Dr Anisha Dua, Northwestern Medical Group, USA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:50

Diagnosis of large vessel vasculitis with imaging

Presented By

Dr Peter Grayson, National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, USA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:50

Knee osteoarthritis patients with indicators of inflammation could profit from methotrexate

Presented By

Prof. Biswadip Ghosh, Institute of Post Graduate Medical Education and Research, India

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:48

Anticoagulation with vitamin K antagonist is associated with risk of knee and hip replacement

Presented By

Dr Priyanka Ballal, Boston University Medical Center, USA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:48

Bisphosphonate use: Asian American women have a smaller treatment benefit

Presented By

Prof. Jinoos Yazdany, University of California San Francisco, USA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:47

Inflammatory disease as a risk factor for fractures

Presented By

Dr Giovanni Adami, University of Verona, Italy

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:45

No progression of osteoarthritis with corticosteroid injections

Presented By

Dr Justin J. Bucci, Boston University School of Medicine, USA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:43

No elevated risk for influenza AE in tofacitinib-treated RA patients

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:42

Hydroxychloroquine use: no indication for arrhythmias in RA and SLE patients

Presented By

Dr Elizabeth Park, Columbia University Irving Medical Center, USA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:41

Children with rheumatic disease have no greater risk of a COVID-19 infection

Presented By

Dr Jonathan S. Hausmann, Harvard Medical School and Boston Children’s Hospital, USA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:40

Insufficient antimalarial supply for rheumatic disease treatment in the early COVID-19 pandemic

Presented By

Ms Emily Sirotich, COVID‐19 Global Rheumatology Alliance Steering Committee and McMaster University, Canada

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:38

ACR 2020 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ACR 2020

12 November 2020 10:59

EULAR 2020

EULAR 2020 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

EULAR 2020

1 September 2020 15:43

Letter from the Editor EULAR 2020

Editor

Prof. Dennis McGonagle, University of Leeds, UK

Conference

EULAR 2020

28 August 2020 16:41

COVID-19 and inflammatory rheumatic disease: some key issues

Presented By

Prof. G. Burmester, Charité University Hospital, Germany

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 15:06

Anifrolumab achieves rapid and durable BICLA-response

Presented By

Prof. Eric Morand, Monash University, Australia

Trial

TULIP-1, TULIP-2

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 15:01

Subclinical myocardial involvement progresses in SSc patients

Presented By

Dr Devis Benfaremo, Università Politecnica delle Marche, Italy

Conference

EULAR 2020

14 August 2020 14:55

Wide variation in prescription and dosing patterns for hydroxychloroquine in SLE

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 14:52

Composite endpoint CRESS for primary Sjögren’s syndrome

Presented By

Dr Suzanne Arends, University Medical Center Groningen, the Netherlands

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 14:43

Higher mortality risk with tramadol versus NSAIDs for osteoarthritis patients

Presented By

Lingyi Li, University of British Columbia, Canada

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 14:37

Hydroxychloroquine not effective in patients with hand osteoarthritis

Presented By

Dr Claudia Kedor, Charité – Universitätsmedizin Berlin, Germany

Trial

OA-TREAT

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 14:34

Positive effect denosumab on fall risk

Presented By

Dr Yasser El Miedany, Darent Valley Hospital, United Kingdom

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 14:27

Ixekizumab shows sustained improvements in pain and fatigue at 3 years

Presented By

Prof. Ana-Maria Orbai, Johns Hopkins University School of Medicine, USA

Trial

SPIRIT-P2

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 14:15

Adalimumab added to methotrexate yields better results in PsA than methotrexate escalatio

Presented By

Dr Laura Coates, Oxford University, United Kingdom

Trial

Phase 4, CONTROL

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 14:09

Upadacitinib provides fast onset of improvement in psoriatic arthritis

Presented By

Prof. Iain McInnes, University of Glasgow, Scotland

Trial

SELECT-PsA-1

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 14:02

Secukinumab monotherapy as efficient as adalimumab

Presented By

Prof. Iain McInnes, University of Glasgow, United Kingdom

Trial

Phase 3, EXCEED

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 13:11

Reduced maintenance dose of certolizumab pegol can be used in axSpA

Presented By

Prof. Robert Landewé, University of Amsterdam, the Netherlands

Trial

C-OPTIMISE

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 10:30

Worse response axSpA patients to second TNFi versus first TNFi

Presented By

Dr Santiago Rodrigues-Manica, Hospital Egas Moniz, Portugal

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 10:27

AxSpA real-life remission rates higher on biologics

Presented By

Dr Charlotte Baert, Saint Luc University Hospital, Belgium

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 10:24

Certolizumab pegol reduces acute anterior uveitis in axial spondyloarthritis

Presented By

Prof. Irene van der Horst-Bruinsma, Amsterdam University Medical Center, the Netherlands

Trial

C-VIEW

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 10:19

TNF-α inhibitors improve bone mineral density in AS patients

Presented By

Mark Siderius, University Medical Center Groningen; Medical Center Leeuwarden, the Netherlands

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 10:13

Preliminary findings suggest rozibafusp alfa effective and tolerable in RA

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 09:56

Immune-related AEs due to checkpoint inhibitors require care coordination

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 09:49

New nanoparticle promising future agent in RA

Presented By

Prof. Kira Astakhova, Technical University of Denmark, Denmark

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 09:43

Olokizumab significantly improves RA features and patient-reported outcomes

Presented By

Prof. Rumen Stoilov, University Hospital St. Ivan Rilski, Bulgaria

Trial

CREDO-1

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 09:33

Low DAS at 4 months predicts sustained DMARD-free remission

Presented By

Ms Marloes Verstappen, Leiden University Medical Center, the Netherlands

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 07:50

ACR 2019

Anifrolumab succeeds in second phase 3 trial in SLE

Presented By

Prof. Eric Morand, Prof. Richard Furie

Trial

Phase 3, TULIP

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 23:44

Lowest risk of infection after therapy with an IL-12/IL-23 blocker

Presented By

Dr Yinzhu Jin, Brigham and Women´s Hospital and Harvard Medical School, Boston, USA

Trial

Cohort study

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 23:42

Antifibrotic therapy slows disease progression independent of corticosteroid use

Presented By

Dr Madelon Vonk, Radboud University, the Netherlands

Trial

SENSCIS

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 23:22

Rituximab maintenance superior to azathioprine in ANCA-associated vasculitis

Presented By

Dr Rona Smith, University of Cambridge, UK

Trial

RITAZAREM

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 23:18

Introduction to the Conference Report of the ACR

Conference

ACR 2019

4 February 2020 23:17

Few serious infections in offspring with exposure to non-TNFi biologics or tofacitinib

Presented By

Dr Evelyne Vinet, McGill University, Montreal, Canada

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 23:12

Psoriasis onset determines sequence of symptoms

Presented By

Prof. Umut Kalyoncu, Hacettepe University, Turkey

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 23:07

Hand OA: low-dose corticosteroids improve symptoms

Presented By

Dr Féline Kroon, Prof. Christian Roux

Trial

HOPE

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 23:07

Filgotinib promising in RA patients naïve to methotrexate

Presented By

Prof. Rene Westhovens, University of Leuven, Belgium

Trial

Phase 3, FINCH 3

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 23:05

Higher psychiatric comorbidity in women with PsA

Presented By

Prof. Mehmet Duruöz, Marmara University Hospital, Turkey

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 22:50

Calcium pyrophosphate deposition disease: an independent risk factor for cardiovascular complications

Presented By

Dr Maaman Bashir, Medical College of Wisconsin, USA

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 22:45

Prevention of congenital heart block may be possible with hydroxychloroquine

Presented By

Prof. Peter Izmirly, New York University School of Medicine, USA

Trial

PATCH

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 22:14

Opioids: no quality of life benefits for OA patients

Presented By

Dr Raveendhara Bannuru, Tufts Medical Center, USA

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 22:08

Sustained efficacy of monotherapy with upadacitinib after 48 weeks

Presented By

Prof. Joseph Smolen, Medical University of Vienna, Austria

Trial

SELECT-MONOTHERAPY

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 22:06

Proteome abnormalities improve prediction of RA development

Presented By

Dr Liam O´Neil, University of Manitoba, Canada

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 21:47

Biologics show similar activity in patients with elderly-onset RA

Presented By

Dr Sadao Jinno, Kobe University School of Medicine, Japan

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 21:08

JAK1 inhibition shows remarkable efficacy in AS

Presented By

Prof. Désirée van der Heijde, Leiden University Medical Center, the Netherlands

Trial

Phase 3, SELECT-AXIS 1

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 20:57

RA patients in remission benefit from continued therapy with conventional DMARDs

Presented By

Dr Siri Lillegraven, Diakonhjemmet Hospital,Norway

Trial

ARCTIC REWIND, TARA

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 20:51

Tocilizumab outperforms rituximab in RA patients with low level of synovial B cell infiltration

Presented By

Prof. Costantino Pitzalis, Barts and The London School of Medicine and Dentistry, UK

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 20:10

Selective IL-23 blocker shows remarkable efficacy in patients with psoriatic arthritis

Presented By

Prof. Atul Deodhar, Oregon Health & Science University, USA

Trial

Phase 3, DISCOVER

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 19:53

Treatment decisions should not be guided by ultrasound findings

Presented By

Dr Espen Haavardsholm, Diakonhjemmet Hospital, Oslo, Norway

Trial

ARCTIC, TaSER

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 19:11

Depression closely related to fatigue in SLE patients

Presented By

Christina Düsing, Universitätsklinikum Düsseldorf, Germany

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 12:47

Cancer treatment with checkpoint inhibitors in RA patients?

Presented By

Dr Sabina Sandigursky, New York University Langone Medical Center, USA

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 11:13

Fibromyalgia patients often experienced abuse in childhood

Presented By

Dr Carmen Gota, Cleveland Clinic, Ohio, USA

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 10:23

Prolonged remission after stop of tocilizumab for patients with giant cell arteritis

Presented By

Prof. John H. Stone, Harvard Medical School, Boston, USA

Trial

Phase 3, GiACTA

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 10:19

TNFi for RA during pregnancy – to stop or not to stop?

Presented By

Dr Isabell Haase, Heinrich-Heine University Düsseldorf, Germany

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 10:16

Walking speed is a predictor of mortality in patients with knee OA

Presented By

Dr Hiral Master, University of Delaware,, USA

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 10:10

CARDAS study shows increased prevalence of cardiac valvular disorders in AS patients

Presented By

Mr Milad Baniaamam, Amsterdam University Medical Center, the Netherlands

Trial

CARDAS

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 10:04

Corticosteroid therapy in GCA: higher platelets – lower relapse rate

Presented By

Dr Samuel Deshayes, Hospital Center University Of Caen Normandie, France

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 09:55

Editor Biography

Editor

Prof. Dennis McGonagle, University of Leeds, England

Conference

ACR 2019

3 February 2020 09:15

EULAR 2019

Interstitial lung disease in rheumatic diseases and systemic sclerosis

Presented By

Dr Jan Grutters, University Medical Center Utrecht, the Netherlands

Trial

SENSCIS, INPULSIS, SLS-2

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 23:50

What is new in osteoarthritis

Presented By

Prof. Francis Berenbaum, Sorbonne Université, France

Trial

Phase 2, ADIPOA-2

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 23:43

Cohort study shows improvement during 25 years of RA treatment

Presented By

Dr Xanthe Matthijssen, Leiden University Medical Center, the Netherlands

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 23:13

Treat-to-target approach emerging in axial spondyloarthritis

Presented By

Dr Pedro Machado, University College London Hospitals, United Kingdom

Trial

TICOPA, TICORA, TICOSPA

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 23:10

Filgotinib in RA patients with inadequate response or naïve to methotrexate

Presented By

Prof. Rene Westhovens, University Hospital Leuven, Belgium

Trial

Phase 3, FINCH-3

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 22:35

Clinical effectiveness of fenebrutinib in RA patients with methotrexate or TNFi failure

Presented By

Dr Stanley Cohen, Metroplex Clinical Research Center, Dallas, USA

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 21:38

Emapalumab in patients with macrophage activation syndrome

Presented By

Dr Fabrizio De Benedetti, Ospedale Pediatrico Bambino Gesù, Italy

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 20:51

Peficitinib likely efficacious and safe

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 20:42

Short methotrexate stop is safe in patients with RA

Presented By

Dr Min Jung Kim, Seoul National University Hospital, South Korea

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 19:47

Tofacitinib is safe according to real-world data analysis

Presented By

Dr Joel Kremer, Albany Medical College, New York, USA

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 18:51

Switching upadacitinib and adalimumab is beneficial in refractory RA

Trial

Phase 3, SELECT-COMPARE

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 17:54

Tapering of prednisone in RA patients who achieved low disease activity or remission with tocilizumab

Presented By

Prof. Gerd Burmester, Free University and Humboldt University of Berlin, Germany

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 16:56

Efficacy and safety of E6011 in RA patients with inadequate response to methotrexate

Presented By

Dr Yoshiya Tanaka, University of Occupational and Environmental Health, Japan

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 15:58

Preliminary efficacy and safety data of RG6125 in RA patients with an inadequate response to TNF inhibitors

Presented By

Uwe Junker, Roche Innovation Center Basel, Switzerland

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 14:01

Integrated 10-year analysis confirms safety profile abatacept

Presented By

Dr Teresa Simon, Bristol-Myers Squibb, USA

Trial

Cohort study, ARTIS, RABBIT, FORWARD, British Columbia Canadian RA Cohort

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 13:03

Switching among multiple infliximab biosimilars does not cause immunogenicity

Presented By

Dr Jéróme Avouac, Paris Descartes University, France

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 12:06

Letter from the Editor

Editor

Prof. Dennis McGonagle, University of Leeds, United Kingdom

Conference

EULAR 2019

4 September 2019 11:30

Efficacy and safety of ixekizumab versus adalimumab in patients with PsA

Presented By

Dr Roy Fleischmann, University of Texas Southwestern Medical Center, Dallas, USA

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 11:20

Efficacy and safety of bimekizumab in patients with active PsA

Presented By

Dr Christopher Ritchlin, University of Rochester Medical Centre, USA

Trial

Phase 2, BE ACTIVE

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 11:10

Filgotinib is efficacious and safe in PsA

Presented By

Prof. Philip Mease, Swedish Medical Center and University of Washington, Seattle, USA

Trial

Phase 2, EQUATOR

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 11:00

Support for tocilizumab use in giant cell arteritis

Presented By

Dr John Stone, Massachusetts General Hospital, Boston, USA

Trial

GiACTA

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 10:53

Ixekizumab improves signs and symptoms in TNFi-naïve PsA patients

Presented By

Dr Amanda Gellett, Eli Lilly, USA

Trial

Phase 3, SPIRIT-P2

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 10:50

How to treat osteoporosis

Presented By

Prof. Serge Ferrari, Geneva University Hospital, Switzerland

Trial

VERO, FREEDOM, GIOP, FRAME

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 10:46

Etanercept and methotrexate as first-line treatment in PsA

Presented By

Prof. Philip Mease, University of Washington, USA

Trial

Phase 3, SEAM-PsA

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 10:40

Unacceptable pain is common in patients with psoriatic arthritis

Presented By

Dr Tor Olofsson, Lund University, Sweden

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 10:33

NSAIDs consumption is linked to patient-assessed disease activity and decreases with use of TNF inhibitors

Presented By

Dr Olafur Palsson, University Hospital Reykjavik, Iceland

Trial

ICEBIO database

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 10:11

Switch to sarilumab from adalimumab is efficacious and safe

Presented By

Dr Gerd Burmester, Free University and Humboldt University of Berlin, Germany

Trial

MONARCH

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 10:07

EULAR 2018

Novel systemic sclerosis drugs: an overview of what might be to come

Trial

Phase 3, RESOLVE-1

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 23:46

Clinical effect of vedolizumab on articular manifestations spondyloarthritis associated with IBD

Presented By

Dr. Paccou, Amiens University Medical Center, France

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 23:43

Osteoporosis and vertebral fractures associated with disease activity/radiographic damage in axial spondyloarthritis

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 23:38

Early, intensive rheumatoid arthritis treatment seems to normalise mortality rates

Trial

COBRA

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 23:36

Letter from the Editor

Editor

Prof. Dennis McGonagle, University of Leeds, United Kingdom

Conference

EULAR 2018

24 August 2018 23:29

Promising results rituximab in systemic sclerosis, and systemic lupus erythematosus classification criteria

Presented By

Prof. Allanore, University of Paris Descartes University, France

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 22:49

Synergistic effect NSAIDs plus TNFi in slowing radiographic progression in ankylosing spondylitis patients

Presented By

Dr Gensler, University of California San Francisco Medical Center, USA

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 22:48

Switching to biosimilar bDMARDs is safe and efficacious

Presented By

Prof. Kvien, University of Oslo and Diakonhjemmet Hospital, Norway

Trial

Phase 4, NOR-SWITCH

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 22:46

Glucosepane is a new biomarker for the severity of osteoarthritis

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 22:40

No significant differences when tapering TNF blockers versus csDMARDs

Presented By

Dr Van Mulligen, Erasmus MC, the Netherlands

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 21:51

miRNA-146A plays key role in bone metabolism and osteoporosis

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 21:42

Low bone mineral density is common in axial spondyloarthritis; more awareness required

Trial

Cohort study, axSpA

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 20:52

Systemic lupus erythematosus: Baricitinib may be potential therapy, and clinical benefit of ustekinumab

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 20:52

Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 20:26

Biologic drug levels and infection risk, and clinical effectiveness of sarilumab

Trial

TARGET

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 19:30

Confirmation of long-term safety profile adalimumab across indications

Presented By

Prof. Gerd Burmester, Charité University Hospital, Free University and Humboldt University of Berlin, Germany

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 18:39

ACR 2018

Letter from the Editor

Editor

Prof. Dennis McGonagle, University of Leeds, United Kingdom

Conference

ACR 2018

24 October 2018 15:56

EULAR 2017

Letter from the Editor

Editor

Prof. F.C. Breedveld, Leiden University Medical Center, the Netherlands

Conference

EULAR 2017

17 June 2017 16:02

ACR 2017

Letter from the Editor

Editor

Prof. Robert J. Moots, University of Liverpool, United Kingdom

Conference

ACR 2017

8 November 2017 16:06